Global PV leadership Navitas Life Sciences operates across eight offices in five countries with a strong pharmacovigilance, regulatory, and clinical solution portfolio, indicating opportunity to upsell integrated PV and regulatory services to multinational pharma and biotech clients expanding globally.

AI driven platforms Proprietary solutions such as OneClinical powered by AI and machine learning, along with near real-time data analytics through pharmaREADY and safetyREADY, present a compelling cross-sell to clients seeking faster trial insights and risk management.

Industry recognition Recognitions from IDC MarketScape and Everest Group, plus top 10 innovator awards, strengthen credibility for pursuing larger-scale engagements in drug safety, clinical development platforms, and life sciences operations with incumbent customers and prospects.

Strategic partnerships Recent collaborations with Glemser and integration of ComplianceAuthor and regulatoryREADY solutions create entry points for consultative selling to sponsors needing regulatory compliance, audit readiness, and data governance enhancements.

Acquisitions and restructuring Historical and recent corporate activity, including acquisitions and divestitures involving H.I.G. Capital, signals a dynamic M&A environment; target customers may require robust transition support, integration services, and continuity in pharmacovigilance and safety operations during restructuring.